A Likely Case of Abemaciclib-Induced Hyperpigmentation in a Patient With Metastatic Breast Cancer.

Salusti-Simpson, Michela; Porter, Hannah; Morley, Keith

Salusti-Simpson, Michela; Porter, Hannah; Morley, Keith.

Affiliation

Salusti-Simpson M; Dermatology, University of Vermont Medical Center, Burlington, USA.
Porter H; Dermatology, University of Vermont Medical Center, Burlington, USA.
Morley K; Dermatology, University of Vermont Medical Center, Burlington, USA.

Cureus ; 14(9): e28948, 2022 Sep.

Article in En | MEDLINE | ID: mdl-36159365

Key words

abemaciclib; adverse cutaneous drug reaction; breast cancer research; cutaneous adverse drug reaction; cutaneous hyperpigmentation; drug-reaction; to illustrate this rarely described cutaneous adverse effect of the drug

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Cureus Year: 2022 Document type: Article

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Cureus Year: 2022 Document type: Article